Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

Vanessa Devine, J M Jefferies, S C Clarke, S N Faust

    Research output: Contribution to journalArticle

    Abstract

    Seven-valent pneumococcal conjugate vaccine (PCV7) was included in the UK national immunisation program in 2006, and this was replaced by thirteen-valent PCV in 2010. During this time, the carriage of vaccine-type Streptococcus pneumoniae decreased but pneumococcal carriage remained stable due to increases in non-vaccine-type S. pneumoniae. Carriage studies have been undertaken in various countries to monitor vaccine-type replacement and to help predict the serotypes, which may cause invasive disease. There has been less focus on how conjugate vaccines indirectly affect colonization of other nasopharyngeal bacteria. If the nasopharynx is treated as a niche, then bacterial dynamics are accepted to occur. Alterations in these dynamics have been shown due to seasonal changes, antibiotic use, and sibling/day care interaction. It has been shown that, following PCV7 introduction, an eradication of pneumococcal vaccine types has resulted in increases in the abundance of other respiratory pathogens including Haemophilus influenzae and Staphylococcus aureus. These changes are difficult to attribute to PCV7 introduction alone and these studies do not account for further changes due to PCV13 implementation. This review aims to describe nasopharyngeal cocarriage of respiratory pathogens in the PCV era.
    LanguageEnglish
    Pages394368
    JournalJournal of immunology research
    Volume2015
    Publication statusAccepted/In press - 16 Aug 2015

    Fingerprint

    Conjugate Vaccines
    Pneumococcal Vaccines
    Streptococcus pneumoniae
    Vaccines
    Immunization Programs
    Nasopharynx
    Haemophilus influenzae
    Staphylococcus aureus
    Anti-Bacterial Agents
    Bacteria
    Serogroup

    Keywords

    • PCV
    • invasive pneumococcal disease
    • carriage
    • serotypes
    • streptococcus pneumoniae

    Cite this

    Devine, V., Jefferies, J. M., Clarke, S. C., & Faust, S. N. (Accepted/In press). Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci. Journal of immunology research, 2015, 394368.
    @article{bc3f796c42a74ca9a2f09becdcb9781a,
    title = "Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.",
    abstract = "Seven-valent pneumococcal conjugate vaccine (PCV7) was included in the UK national immunisation program in 2006, and this was replaced by thirteen-valent PCV in 2010. During this time, the carriage of vaccine-type Streptococcus pneumoniae decreased but pneumococcal carriage remained stable due to increases in non-vaccine-type S. pneumoniae. Carriage studies have been undertaken in various countries to monitor vaccine-type replacement and to help predict the serotypes, which may cause invasive disease. There has been less focus on how conjugate vaccines indirectly affect colonization of other nasopharyngeal bacteria. If the nasopharynx is treated as a niche, then bacterial dynamics are accepted to occur. Alterations in these dynamics have been shown due to seasonal changes, antibiotic use, and sibling/day care interaction. It has been shown that, following PCV7 introduction, an eradication of pneumococcal vaccine types has resulted in increases in the abundance of other respiratory pathogens including Haemophilus influenzae and Staphylococcus aureus. These changes are difficult to attribute to PCV7 introduction alone and these studies do not account for further changes due to PCV13 implementation. This review aims to describe nasopharyngeal cocarriage of respiratory pathogens in the PCV era.",
    keywords = "PCV, invasive pneumococcal disease, carriage, serotypes, streptococcus pneumoniae",
    author = "Vanessa Devine and Jefferies, {J M} and Clarke, {S C} and Faust, {S N}",
    year = "2015",
    month = "8",
    day = "16",
    language = "English",
    volume = "2015",
    pages = "394368",
    journal = "Journal of immunology research",
    issn = "2314-8861",

    }

    Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci. / Devine, Vanessa; Jefferies, J M; Clarke, S C; Faust, S N.

    In: Journal of immunology research, Vol. 2015, 16.08.2015, p. 394368.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

    AU - Devine, Vanessa

    AU - Jefferies, J M

    AU - Clarke, S C

    AU - Faust, S N

    PY - 2015/8/16

    Y1 - 2015/8/16

    N2 - Seven-valent pneumococcal conjugate vaccine (PCV7) was included in the UK national immunisation program in 2006, and this was replaced by thirteen-valent PCV in 2010. During this time, the carriage of vaccine-type Streptococcus pneumoniae decreased but pneumococcal carriage remained stable due to increases in non-vaccine-type S. pneumoniae. Carriage studies have been undertaken in various countries to monitor vaccine-type replacement and to help predict the serotypes, which may cause invasive disease. There has been less focus on how conjugate vaccines indirectly affect colonization of other nasopharyngeal bacteria. If the nasopharynx is treated as a niche, then bacterial dynamics are accepted to occur. Alterations in these dynamics have been shown due to seasonal changes, antibiotic use, and sibling/day care interaction. It has been shown that, following PCV7 introduction, an eradication of pneumococcal vaccine types has resulted in increases in the abundance of other respiratory pathogens including Haemophilus influenzae and Staphylococcus aureus. These changes are difficult to attribute to PCV7 introduction alone and these studies do not account for further changes due to PCV13 implementation. This review aims to describe nasopharyngeal cocarriage of respiratory pathogens in the PCV era.

    AB - Seven-valent pneumococcal conjugate vaccine (PCV7) was included in the UK national immunisation program in 2006, and this was replaced by thirteen-valent PCV in 2010. During this time, the carriage of vaccine-type Streptococcus pneumoniae decreased but pneumococcal carriage remained stable due to increases in non-vaccine-type S. pneumoniae. Carriage studies have been undertaken in various countries to monitor vaccine-type replacement and to help predict the serotypes, which may cause invasive disease. There has been less focus on how conjugate vaccines indirectly affect colonization of other nasopharyngeal bacteria. If the nasopharynx is treated as a niche, then bacterial dynamics are accepted to occur. Alterations in these dynamics have been shown due to seasonal changes, antibiotic use, and sibling/day care interaction. It has been shown that, following PCV7 introduction, an eradication of pneumococcal vaccine types has resulted in increases in the abundance of other respiratory pathogens including Haemophilus influenzae and Staphylococcus aureus. These changes are difficult to attribute to PCV7 introduction alone and these studies do not account for further changes due to PCV13 implementation. This review aims to describe nasopharyngeal cocarriage of respiratory pathogens in the PCV era.

    KW - PCV

    KW - invasive pneumococcal disease

    KW - carriage

    KW - serotypes

    KW - streptococcus pneumoniae

    M3 - Article

    VL - 2015

    SP - 394368

    JO - Journal of immunology research

    T2 - Journal of immunology research

    JF - Journal of immunology research

    SN - 2314-8861

    ER -